SKA2 and renal cell carcinoma: To validate the clinical significance of SKA complex subunits 1,2 and 3 in RCC pathogenesis, we asked whether the expression levels of SKA1, SKA2 and SKA3 were associated with the duration of disease-free survival (DFS) in RCC patients.